(Q33681462)

28 July 2017

title

Optic neuritis associated with adalimumab in the treatment of uveitis (English)

1 reference

28 July 2017

Optic Neuritis Associated with Adalimumab in the Treatment of Uveitis (English)

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

4 July 2024

0 references

1 reference

1 reference

1 reference

Sing Your Li

1

1 reference

28 July 2017

Andrea D. Birnbaum

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20809867

4 July 2024

Debra A. Goldstein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20809867

4 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20809867

4 July 2024

publication date

1 September 2010

1 reference

full work available at URL

28 July 2017

http://www.tandfonline.com/doi/pdf/10.3109/09273948.2010.495814

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

Ocular Immunology and Inflammation

4 July 2024

published in

1 reference

28 July 2017

volume

18

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

475-481

1 reference

TNFalpha blockade in human diseases: an overview of efficacy and safety

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Inflammatory demyelinating events following treatment with anti-tumor necrosis factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Adalimumab-associated optic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Retrobulbar optic neuritis associated with infliximab in a patient with Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Bilateral anterior toxic optic neuropathy and the use of infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Infliximab-associated retrobulbar optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Optic neuritis occurring with anti-tumour necrosis factor alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Sudden visual loss in a child with juvenile idiopathic arthritis-related uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Optic neuritis associated with etanercept therapy for juvenile arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Optic neuritis with concurrent etanercept and isoniazid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

Increased risk for demyelinating diseases in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2010.495814

The Journal of Rheumatology

21 January 2018

5

31

1955

Mohan N

2004

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

CNS demyelination during anti–tumor necrosis factor alpha therapy

4 July 2024

7

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

New-onset demyelination induced by infliximab therapy in two rheumatoid arthritis patients

4 July 2024

8

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

Acute paraplegia after the initiation of anti-tumour necrosis factor-alpha therapy for Crohn's disease

4 July 2024

9

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy

4 July 2024

11

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

The Journal of Rheumatology

4 July 2024

12

33

1018

Jarand J

2006

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

[Demyelinating neuropathy during anti-TNF alpha treatment with a review of the literature]

4 July 2024

13

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

Anterior optic neuropathy associated with adalimumab

4 July 2024

16

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

The Journal of Rheumatology

4 July 2024

17

34

239

Bensouda-Grimaldi L

2007

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

4 July 2024

19

120

985

Foroozan R

2002

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

[Optic neuritis associated with infliximab]

4 July 2024

21

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

Infliximab-induced retrobulbar optic neuritis

4 July 2024

25

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

[Retrobulbar optic neuritis associated with Infliximab]

4 July 2024

26

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

[Retrobulbar optic neuritis during infliximab treatment for ulcerative colitis]

4 July 2024

27

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group

4 July 2024

33

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis

4 July 2024

39

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

Family history of inflammatory bowel disease in patients with idiopathic ocular inflammation

4 July 2024

40

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis

4 July 2024

41

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

Association of MS with thyroid disorders

4 July 2024

42

1 reference

https://api.crossref.org/works/10.3109/09273948.2010.495814

4 July 2024

Identifiers

1 reference

28 July 2017

1 reference